Long-term exposure to leptin enhances the growth of prostate cancer cells

Abstract

Obesity correlates with an increased risk of developing prostate cancer (PCa) and leptin plays an important role in PCa progression. Since leptin is produced by adipocytes, the serum leptin level is higher in obese than in non-obese individuals. However, the effects of leptin remain controversial and unclear. The aim of the present study was to investigate the effect of leptin on PCa cell aggressiveness. Three human PCa cell lines (LNCaP, DU145 and PC-3) were treated with recombinant leptin for 28 days. Cell proliferation, migration, and invasion were estimated using the WST assay, a wound-healing assay, and a BD Matrigel invasion assay, respectively. The mechanism underlying the proliferative effect of leptin was investigated by cell transfections with small interfering RNA (siRNA) against the leptin receptor (ObR) or forkhead box O1 (FOXO1), and by immunocytochemistry. Long-term exposure of PCa cells to leptin enhanced their proliferation, migration and invasion. Leptin increased ObR expression and enhanced Akt phosphorylation constitutively. Leptin also increased the phosphorylation of FOXO1 via PI3K signaling and FOXO1 gene silencing enhanced PCa cell proliferation. Leptin induced the translocation of FOXO1 from the nucleus to the cytoplasm. Furthermore, the PI3K inhibitor, LY294002 suppressed this translocation. These results suggested that leptin regulated the subcellular localization of FOXO1 and induced Akt phosphorylation. Additionally, we revealed that leptin increased the expression of cyclin D1 and decreased the expression of p21 protein. In conclusion, long-term exposure to leptin increased the cell proliferation, migration, and invasion of PCa cells through inactivation of FOXO1. This inactivation resulted from exclusion of FOXO1 from the nucleus and its restriction to the cytoplasm through PI3K/Akt signaling. Our findings contribute to an understanding of the association between obesity and PCa aggressiveness.

Serum 17β-estradiol fails as a marker in identification of aggressive tumour disease in patients with localized prostate cancer

“…However, the effects of leptin remain controversial and unclear [28]. Long-term exposure of PC cells to leptin enhances their proliferation, migration and invasion, and leptin increases the leptin receptor expression and enhances prokinase B (Akt) phosphorylation constitutively, as postulated currently by Noda et al [29].…”

Genetic polymorphisms in leptin, adiponectin and their receptors affect risk and aggressiveness of prostate cancer: evidence from a meta-analysis and pooled-review

“…Several studies demonstrated that the variants might elevate the serum leptin level through transcriptional level, and increase human body weight as well [39, 40]. Higher leptin level, in turn, contributed to cancer growth and development via stimulating inflammation, angiogenesis, proliferation and epithelial-mesenchymal transition [10, 41]. …”

Markers of accessory glands and seminal parameters in infertile men with overweight and obesity

“…Several isoforms of the leptin receptor have been reported in human tissues including the prostate and testes [18,19]. In this study, no diagnosis or follow-up of prostate cancer was performed as Canacci et al [20], they studied the chemicals products in the male accessory glands and related them to the Gleason score [20].…”